News

U.S. Senator John Fetterman (D-PA) has strongly criticized recent Trump administration policies that could compromise the ...
Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...
Fetterman's Small Donor Revolt Highlights Betrayal of Grassroots Support** In a stunning turn of events for the Democratic Party, Senator John Fetterman of Pen ...
The FDA warned that several hundred units of counterfeit 1-mg semaglutide (Ozempic) were found in the U.S. drug supply chain ...
John Fetterman urged Trump to reverse his decision to pull a Biden-era proposal that would have made GLP-1 medications more ...
In a New York Times op-ed on April 8, Sen. John Fetterman, D-Pa., wrote about his experience with Mounjaro (tirzepatide). The ...
Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...